|
Market Closed -
Toronto S.E.
03:13:00 2026-08-28 pm EDT
|
5-day change | 1st Jan Change | ||
| 0.4900 CAD | +0.51% |
|
-2.00% | +7.69% |
| Aug. 27 | Pharmacorp Rx Inc. Announces Board and Committee Changes, Effective from August 31, 2026 | CI |
| Aug. 20 | PharmaCorp Rx Swings to Q2 Profit as Revenue Jumps | MT |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | 49x | - | 1.82x | 22.63x | 53.09x | 61.39M | |
| -.--% | -.--% | 16.78x | 1.51x | 0.68x | 10.1x | 10.99x | 14.92B | |
| 1.07% | 1.33% | 20.98x | 2.36x | 0.8x | 13.48x | 13.73x | 6.48B | |
| 2.19% | 2.51% | 16.99x | 1.75x | 0.77x | 7.98x | 10.01x | 6.45B | |
| 3.26% | 3.35% | 14.75x | 2.17x | 0.95x | 7.07x | 8.67x | 4.12B | |
| 5.51% | 6.05% | 14.61x | 4.42x | 1.25x | 7.66x | 14.37x | 3.25B | |
| 5.23% | 5.78% | 13.86x | 2.63x | 0.58x | 4.77x | 7.48x | 3.07B | |
| 4.64% | 5.09% | 13.83x | 6.26x | 0.83x | 6.24x | 8.68x | 2.91B | |
| 2% | 2.43% | 20.51x | 3.59x | 0.6x | 7.65x | 12.52x | 1.53B | |
| 0.02% | -.--% | -131.05x | 2.72x | 0.45x | 16.1x | 69.56x | 1.52B | |
| 3.32% | 4.53% | 13.91x | 0.87x | 0.29x | 3.09x | 6.73x | 960M | |
| 5.84% | 5.85% | 18.23x | 2.2x | 0.83x | 7.58x | 17.88x | 883M | |
| 1.31% | 1.9% | 27.32x | 7.45x | 0.99x | 13.48x | 20.89x | 829M | |
| Average | 2.87% | 3.23% | 8.44x | 3.16x | 0.83x | 9.83x | 19.58x | 3.62B | |
| Weighted average by Cap. | 2.01% | 2.25% | 12.23x | 2.50x | 0.77x | 9.25x | 13.10x |
- Stock Market
- Stocks
- PCRX Stock
- Sector PharmaCorp Rx Inc.
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
